Gain Therapeutics
Price & Volume
Stats
See moreOpen | $1.72 |
Previous Close | $1.74 |
Day Range | $1.68-$1.78 |
52W Range | $1.41-$3.19 |
Market Cap | $62.9M |
Shares Short | 233,336 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$8.7M |
Diluted EPS | -$0.59 |
News
See moreYahoo Finance • 2 days ago
Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
Yahoo Finance • 7 days ago
Gain Therapeutics Begins Its GT-02287 Phase 1b Extension Study in People with Parkinson’s Disease
Yahoo Finance • last month
H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock at $8 price target
Yahoo Finance • 2 months ago
Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference
About
CEO | Mr. Gene Mack M.B.A. |
Address | 4800 Montgomery Lane, Bethesda, MD, United States, 20814 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
